A Comparison Between Two Formulations of NN5401 in Healthy Subjects

ClinicalTrials.gov ID: NCT01125553

Public ClinicalTrials.gov record NCT01125553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 11, 2026, 9:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial to Test for Bioequivalence Between Two NN5401 Formulations in Healthy Subjects

Study identification

NCT ID: NCT01125553
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Novo Nordisk A/S; Industry
Enrollment: 26 participants

Conditions and interventions

Conditions

Interventions

insulin degludec/insulin aspart Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 55 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 30, 2010
Primary completion: Jul 31, 2010
Completion: Jul 31, 2010
Last update posted: Sep 24, 2015

2010

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Novo Nordisk Clinical Trial Call Center	Chula Vista	California	91911	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01125553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 24, 2015 · Synced May 11, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01125553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →